AZ checkpoint blocker combo fails in head and neck cancer - European Biotechnology

AZ checkpoint blocker combo fails in head and neck cancer  European Biotechnology

British drugmaker AstraZeneca (AZ) has missed another opportunity to secure a share in the lucrative immunoncology market: a Phase III trial combining ...

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2EbMULY